M12-914
ClinicalTrials.gov NCT02163694
Research payments
$632,725
Through program year 2020, $632,725 in research payments was reported against M12-914, across 208 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02163694
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $121,295 | 65 |
| 2019 | Research | $511,430 | 143 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Henry Kaplan Seattle, WA Named on 26 payments
- Hyo Han Miami, FL Named on 24 payments
- Foluso Ademuyiwa Saint Louis, MO Named on 11 payments
- Dana Zakalik Royal Oak, MI Named on 9 payments
- Jane Skelton Delray Beach, FL Named on 8 payments
- Marianne Melnik Grand Rapids, MI Named on 7 payments
- Teresa Helsten La Jolla, CA Named on 6 payments
- Joseph Ferrucci Newton, MA Named on 6 payments
- Banu Arun Houston, TX Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.